


Classification: Selective Estrogen Receptor Modulator (SERM)
Active substance: Tamoxifen Citrate
Manufacturer: Dragon Pharma
Form/Strength: Tablet, 20 mg/tablet
Pack size: 100 tablets
Route: Oral
Lab Test: View Result
For bodybuilders and athletes committed to proper post-cycle therapy and estrogen management, Dragon Pharma Nolvadex represents the gold standard in Selective Estrogen Receptor Modulators (SERMs). Containing 20mg of pharmaceutical-grade Tamoxifen Citrate per tablet, this time-tested compound offers reliable estrogen receptor blockade and effective stimulation of natural testosterone production. As one of the most trusted PCT medications in the bodybuilding community, Nolvadex provides crucial protection against gynecomastia while facilitating recovery of the hypothalamic-pituitary-testicular axis (HPTA) after suppressive cycles. Sourced from the reputable Dragon Pharma laboratory, this product delivers consistent dosing accuracy and pharmaceutical-grade purity that discerning athletes demand for their recovery protocols.
Nolvadex (Tamoxifen Citrate) operates through a sophisticated dual mechanism as a selective estrogen receptor modulator. Its primary action involves competitively binding to estrogen receptors throughout the body, particularly in breast tissue, preventing estrogen from activating these receptors. This blockade is crucial for preventing estrogenic side effects like gynecomastia.
For performance enhancers, the effects of Dragon Pharma Nolvadex are most valuable during post-cycle therapy and when managing estrogen-related side effects. By blocking estrogen's negative feedback on the hypothalamus, Nolvadex stimulates increased production of Gonadotropin-Releasing Hormone (GnRH), which in turn prompts the pituitary gland to secrete more Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH). These gonadotropins then signal the testes to resume natural testosterone production. According to research published by the National Institutes of Health, tamoxifen demonstrates significant efficacy in stimulating gonadotropin secretion while providing protective effects against estrogen-dependent tissues.
Proper Nolvadex dosing depends on your specific goals, whether for post-cycle therapy, on-cycle estrogen control, or gynecomastia treatment. The appropriate dosage varies based on the context of use and individual response.
For Post-Cycle Therapy (PCT): A common protocol involves 20-40mg daily for the first 2-3 weeks, followed by 10-20mg daily for an additional 2-3 weeks. This typically begins 2-3 weeks after your last injection of long-ester compounds. For on-cycle estrogen control: 10-20mg every other day or daily is often sufficient to manage estrogen-related side effects while preserving estrogen's beneficial effects on joints and cholesterol. For gynecomastia treatment or prevention: 20-40mg daily until symptoms subside, then maintenance at 10-20mg daily or every other day. Nolvadex is typically taken once or twice daily, with or without food. The 20mg tablet allows for easy splitting to achieve precise 10mg doses when needed. Recent pharmaceutical studies of Dragon Pharma Nolvadex authentic pills confirm consistent bioavailability whether taken with food or on an empty stomach, though taking with food may minimize potential gastrointestinal discomfort for sensitive users.
Nolvadex serves multiple roles in cycle management, from preventive estrogen control to post-cycle recovery. Strategic implementation is crucial for maintaining hormonal balance and achieving optimal results.
When used at appropriate doses, Nolvadex is generally well-tolerated by most users. However, like all medications, it can cause side effects, particularly at higher doses or in sensitive individuals.
Potential side effects may include:
These effects are typically dose-dependent and often diminish with continued use or dosage reduction. To minimize risks, always use the lowest effective dose and consider regular eye examinations with long-term use. Those with personal or family history of blood clots should exercise caution and consult with a healthcare provider before using Nolvadex.
Understanding the differences between Nolvadex and other Selective Estrogen Receptor Modulators is crucial for making informed decisions about your estrogen management strategy. Nolvadex stands apart from other SERMs in several important aspects that make it particularly valuable for bodybuilding applications.
Compared to Clomid (Clomiphene Citrate), which contains both enclomiphene and zuclomiphene isomers, Nolvadex provides more consistent estrogen receptor blockade without the estrogenic activity associated with zuclomiphene. This often results in fewer mood-related side effects and visual disturbances. Unlike Raloxifene, which primarily targets bone tissue, Nolvadex has stronger activity in breast tissue, making it more effective for gynecomastia prevention and treatment. Nolvadex also has a well-established safety profile with decades of clinical use and research, providing confidence in its effects and side effect profile when used at bodybuilding doses.
In the critical context of post-cycle recovery and estrogen management, where product quality directly impacts your ability to maintain gains and avoid side effects, Dragon Pharma's commitment to excellence makes their Nolvadex the preferred choice for discerning athletes. Each batch undergoes rigorous quality control to ensure accurate dosing and pharmaceutical-grade purity—essential factors for a compound where consistent receptor binding is crucial for effectiveness. The recent lab verification (April 2025) confirming 21.05mg of active Tamoxifen Citrate per tablet demonstrates Dragon Pharma's commitment to exceeding label claims rather than merely meeting them. The 20mg tablet formulation allows for flexible dosing strategies, while the 100-tablet pack provides sufficient quantity for complete PCT protocols or extended estrogen management needs.
Date: 2025-04-18
Result: 21.05 mg/tab
Nolvadex and Clomid are both SERMs but have different properties and applications in PCT. Nolvadex (Tamoxifen) is generally more effective at blocking estrogen receptors in breast tissue, making it superior for preventing and treating gynecomastia. Clomid (Clomiphene) may provide slightly stronger stimulation of LH production in some individuals. Many users find Nolvadex causes fewer visual disturbances and mood-related side effects than Clomid. Some advanced protocols use both medications together—Nolvadex for estrogen blockade and gynecomastia prevention, and Clomid for stronger LH stimulation—though this approach requires careful dosing to avoid excessive estrogen suppression.
The timing depends on the half-lives of the compounds you used. For short esters like testosterone propionate or trenbolone acetate, begin Nolvadex 3-4 days after your last injection. For longer esters like testosterone enanthate or decanoate, wait 14-18 days after your last injection. For compounds with very long half-lives like Deca-Durabolin (nandrolone decanoate), you may need to wait 3-4 weeks before starting PCT. The general rule is to wait approximately 5 half-lives of the compound before beginning SERM therapy to allow sufficient clearance and avoid fighting against the suppressive effects of remaining exogenous hormones.
Yes, Nolvadex can be used during a cycle for estrogen control, particularly for managing or preventing gynecomastia. During-cycle use typically involves lower doses (10-20mg daily or every other day) compared to PCT dosages. This approach blocks estrogen receptors in breast tissue while allowing estrogen to continue providing beneficial effects elsewhere in the body (joint lubrication, cholesterol metabolism, etc.). However, during-cycle SERM use may not prevent the hypothalamic-pituitary suppression caused by exogenous hormones, so a proper PCT is still necessary after the cycle concludes.
Signs of excessive Nolvadex dosage may include severe hot flashes, significant mood changes or depression, visual disturbances such as blurred vision or difficulty focusing, headaches, and excessive suppression of estrogen leading to joint pain or low mood. If you experience these symptoms, particularly visual changes, reduce your dosage immediately or discontinue use until symptoms resolve, then restart at a lower dose. Most users find 10-20mg daily sufficient for PCT purposes, with higher doses (40mg) reserved for the first week or two of PCT or for treating existing gynecomastia.
A standard Nolvadex PCT protocol lasts 4-6 weeks, though this can vary based on the length and intensity of your previous cycle. A common approach is 40mg daily for week 1, 30mg daily for week 2, 20mg daily for week 3, and 10mg daily for week 4. For longer or more suppressive cycles (especially those containing nandrolone or trenbolone), extending to 6-8 weeks may be beneficial. The optimal duration should be guided by post-PCT blood work to confirm successful recovery of natural testosterone production, LH, and FSH levels. Some users continue with a maintenance dose of 10mg every other day for an additional 2-4 weeks if recovery appears incomplete.
Please log in to write Nolvadex 20 mg review.